BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Biondi-Zoccai GG, Agostoni P, Abbate A, Testa L, Burzotta F, Lotrionte M, Crea F, Biasucci LM, Vetrovec GW, Colombo A. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials. Int J Cardiol. 2005;100:119-123. [PMID: 15820294 DOI: 10.1016/j.ijcard.2004.11.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Biondi-Zoccai G, Anderson LA. What is the purpose of launching World Journal of Meta-AnalysisWorld J Meta-Anal 2013; 1(1): 1-4 [DOI: 10.13105/wjma.v1.i1.1] [Reference Citation Analysis]
2 O'Regan C, Ghement I, Eyawo O, Guyatt GH, Mills EJ. Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials 2009;10:86. [PMID: 19772573 DOI: 10.1186/1745-6215-10-86] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
3 Funabashi N, Maeda F, Nakamura K, Suzuki K, Mita Y, Asano M, Narumi H, Kurokawa M, Komuro I. Patency of the left coronary artery by 64-slice multislice computed tomography following implantation of sirolimus-eluting stent. International Journal of Cardiology 2006;111:333-5. [DOI: 10.1016/j.ijcard.2005.11.058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
4 Oguri M, Kato K, Hibino T, Yokoi K, Segawa T, Matsuo H, Watanabe S, Nozawa Y, Murohara T, Yamada Y. Genetic risk for restenosis after coronary stenting. Atherosclerosis 2007;194:e172-8. [DOI: 10.1016/j.atherosclerosis.2006.12.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
5 Zeppetella G, Davies A, Eijgelshoven I, Jansen JP. A Network Meta-Analysis of the Efficacy of Opioid Analgesics for the Management of Breakthrough Cancer Pain Episodes. Journal of Pain and Symptom Management 2014;47:772-785.e5. [DOI: 10.1016/j.jpainsymman.2013.05.020] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
6 Biondi-zoccai GG, Agostoni P, Sangiorgi GM, Colombo A. The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus Taxus: . Journal of Cardiovascular Medicine 2006;7:2-4. [DOI: 10.2459/01.jcm.0000199776.96148.ab] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Biondi-zoccai G, Moretti C, Abbate A, Sheiban I. Percutaneous coronary intervention for small vessel coronary artery disease. Cardiovascular Revascularization Medicine 2010;11:189-98. [DOI: 10.1016/j.carrev.2009.04.007] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
8 Mcmillan WD, Leville CD, Long TD, Gomes M, Groffsky JL, Schultz SR. Drug-eluting Tibial Stents: Objective Patency Determination. Journal of Vascular and Interventional Radiology 2010;21:1825-9. [DOI: 10.1016/j.jvir.2010.09.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 Biondi-Zoccai G, Abbate A, Benedetto U, Palmerini T, D'Ascenzo F, Frati G. Network meta-analysis for evidence synthesis: what is it and why is it posed to dominate cardiovascular decision making? Int J Cardiol 2015;182:309-14. [PMID: 25585376 DOI: 10.1016/j.ijcard.2015.01.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
10 Biondi-zoccai G, D'ascenzo F, Abbate A, Agostoni P, Modena MG. Agreement between adjusted indirect comparison and simplified network meta-analyses on prasugrel and ticagrelor (Reply to Passaro et al. — Int J Cardiol 2011). International Journal of Cardiology 2011;151:228-9. [DOI: 10.1016/j.ijcard.2011.06.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 D'ascenzo F, Biondi-zoccai G. Network Meta-Analyses: The “White Whale” for Cardiovascular Specialists. Journal of Cardiothoracic and Vascular Anesthesia 2014;28:169-73. [DOI: 10.1053/j.jvca.2013.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Biondi-Zoccai GG, Lotrionte M, Anselmino M, Moretti C, Agostoni P, Testa L, Abbate A, Cosgrave J, Laudito A, Trevi GP, Sheiban I. Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J 2008;155:1081-9. [PMID: 18513523 DOI: 10.1016/j.ahj.2007.12.024] [Cited by in Crossref: 80] [Cited by in F6Publishing: 60] [Article Influence: 6.2] [Reference Citation Analysis]
13 Testa L, Zoccai GB, Porto I, Trotta G, Agostoni P, Andreotti F, Crea F. Adjusted Indirect Meta-Analysis of Aspirin Plus Warfarin at International Normalized Ratios 2 to 3 Versus Aspirin Plus Clopidogrel After Acute Coronary Syndromes. The American Journal of Cardiology 2007;99:1637-42. [DOI: 10.1016/j.amjcard.2007.01.052] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
14 Raja SG. Drug-Eluting Stents and the Future of Coronary Artery Bypass Surgery: Facts and Fiction. The Annals of Thoracic Surgery 2006;81:1162-71. [DOI: 10.1016/j.athoracsur.2005.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
15 Biondi-zoccai GG, Sangiorgi GM, Antoniucci D, Grube E, Di Mario C, Reimers B, Tamburino C, Agostoni P, Cosgrave J, Colombo A. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients. International Journal of Cardiology 2007;117:349-54. [DOI: 10.1016/j.ijcard.2006.05.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
16 Biondi-zoccai G, Valgimigli M, Margheri M, Marzocchi A, Lettieri C, Stabile A, Petronio AS, Binetti G, Bolognese L, Bellone P, Sardella G, Contarini M, Sheiban I, Marra S, Piscione F, Romeo F, Colombo A, Sangiorgi G. Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial. American Heart Journal 2012;163:835.e1-7. [DOI: 10.1016/j.ahj.2012.02.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
17 Bavry AA, Bhatt DL. Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. The Lancet 2008;371:2134-43. [DOI: 10.1016/s0140-6736(08)60922-8] [Cited by in Crossref: 97] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
18 Raja SG, Dreyfus GD. Efficacy and Safety of Drug-Eluting Stents: Current Best Available Evidence. J Cardiac Surgery 2006;21:605-12. [DOI: 10.1111/j.1540-8191.2006.00325.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
19 Annemans L, Lemkuhl H, Tenderich G, Schulz U, Yang X, Ricci J, Hetzer R. Economic Evaluation of Everolimus and Mycophenolate Mofetil Versus Azathioprine in De Novo Heart Transplantation. Transplantation Proceedings 2007;39:3306-12. [DOI: 10.1016/j.transproceed.2007.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Donegan S, Williamson P, Gamble C, Tudur-Smith C. Indirect comparisons: a review of reporting and methodological quality. PLoS One. 2010;5:e11054. [PMID: 21085712 DOI: 10.1371/journal.pone.0011054] [Cited by in Crossref: 83] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
21 Sangiorgi G, Romagnoli E, Biondi-zoccai G, Margheri M, Tamburino C, Barbagallo R, Falchetti E, Vittori G, Agostoni P, Cosgrave J, Colombo A. Percutaneous coronary implantation of sirolimus-eluting stents in unselected patients and lesions: Clinical results and multiple outcome predictors. American Heart Journal 2008;156:871-8. [DOI: 10.1016/j.ahj.2008.06.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
22 Uthamalingam S, Ahmado I, Selvaraj V, Dewey R, Flynn J. Long term outcomes in octogenarians undergoing percutaneous coronary intervention: Comparison of bare metal versus drug eluting stent. International Journal of Cardiology 2015;179:385-9. [DOI: 10.1016/j.ijcard.2014.11.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
23 Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011;14:417-428. [PMID: 21669366 DOI: 10.1016/j.jval.2011.04.002] [Cited by in Crossref: 595] [Cited by in F6Publishing: 553] [Article Influence: 59.5] [Reference Citation Analysis]
24 Biondi-zoccai GG, Lotrionte M, Agostoni P, Valgimigli M, Abbate A, Sangiorgi G, Moretti C, Sheiban I. Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regression. American Heart Journal 2007;153:587-93. [DOI: 10.1016/j.ahj.2007.01.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
25 Sheiban I, Villata G, Bollati M, Sillano D, Lotrionte M, Biondi-Zoccai G. Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V). Vasc Health Risk Manag 2008;4:31-8. [PMID: 18629361 DOI: 10.2147/vhrm.2008.04.01.31] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
26 Biondi-Zoccai G, Lotrionte M, Gaita F. Alternatives to clopidogrel for acute coronary syndromes: Prasugrel or ticagrelor? World J Cardiol 2010; 2(6): 131-134 [PMID: 21160730 DOI: 10.4330/wjc.v2.i6.131] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
27 Biondi-Zoccai G, Lotrionte M, Agostoni P, Abbate A, Romagnoli E, Sangiorgi G, Angiolillo DJ, Valgimigli M, Testa L, Gaita F. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes. Int J Cardiol. 2011;150:325-331. [PMID: 20828843 DOI: 10.1016/j.ijcard.2010.08.035] [Cited by in Crossref: 98] [Cited by in F6Publishing: 83] [Article Influence: 8.9] [Reference Citation Analysis]
28 Beijk MA, Piek JJ. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent. Expert Review of Medical Devices 2014;4:11-21. [DOI: 10.1586/17434440.4.1.11] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
29 Verdoia M, Kedhi E, Suryapranata H, Frati G, Biondi-Zoccai G, De Luca G. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials. J Thromb Thrombolysis 2020;50:337-54. [PMID: 31919736 DOI: 10.1007/s11239-019-02033-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Biondi-zoccai GG, Lotrionte M, Abbate A, Valgimigli M, Testa L, Burzotta F, Crea F, Agostoni P. Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients. International Journal of Cardiology 2007;114:104-5. [DOI: 10.1016/j.ijcard.2005.11.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
31 Ouldzein H, Roncalli J, Zouaoui W, Bongard V, Boudou N, Dumonteil N, Lhermusier T, Elbaz M, Puel J, Carrié D. Drug-eluting or bare-metal stents in subjects over 75 years of age: what is the best therapeutic strategy? Data from 460 consecutive patients with 1-year outcome. Cardiovascular Revascularization Medicine 2009;10:94-102. [DOI: 10.1016/j.carrev.2008.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Akulian JA, Yarmus L. If they don't degrade can indwelling pleural catheters evolve? Respirology 2016;21:787-8. [PMID: 27222077 DOI: 10.1111/resp.12822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Heir JS, Gottumukkala V, Singh M, Yusuf SW, Riedel B. Coronary Stents and Noncardiac Surgery: Current Clinical Challenges and Conundrums. Preventive Cardiology 2010;13:8-13. [DOI: 10.1111/j.1751-7141.2009.00044.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]